| Serial Number | 88462498 |
| Word Mark | QULAB |
| Filing Date | Thursday, June 6, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 14, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 17, 2020 |
| Goods and Services | Downloadable computer software for drug discovery; downloadable computer software for the purpose of enabling automated molecular design; downloadable computer software for automated molecular design; downloadable computer software for design of molecules and synthetic chemicals using a biomolecular algorithm; downloadable computer software for biomolecule simulation in connection with drug and chemical design; downloadable computer software utilizing artificial intelligence and machine learning for biomolecule simulation and synthetic chemistry; downloadable computer software for validating novel disease-related targets; downloadable computer software incorporating artificial intelligence and quantum computing functions to automate drug and chemical discovery and development; downloadable computer software incorporating artificial intelligence and quantum computing functions to automate synthetic chemical discovery and development; downloadable computer software for computational automation of synthetic chemicals; downloadable computer software incorporating machine learning algorithms, models, and solutions for applications in pharmacology, biopharmaceuticals, energy, and optoelectronics; downloadable computer software for manipulating molecules; downloadable computer software for use in connection with pharmaceutical research and development in the fields of oncology, immunology, cardiology, pulmonology, CNS, psychiatry, dermatology, and endocrinology; downloadable computer software for pharmaceutical research and development in connection with infectious diseases, diabetes, metabolic diseases, internal diseases, and respiratory diseases |
| Goods and Services | Consultation services in the field of custom manufacturing of pharmaceuticals and biopharmaceuticals |
| Goods and Services | Providing temporary use of on-line non-downloadable software for drug discovery; providing temporary use of on-line non-downloadable software development tools for the purpose of enabling automated molecular design; providing temporary use of on-line non-downloadable software for automated molecular design; design and development of computer software; computer software platform for design of molecules and synthetic chemicals using a search algorithm; providing an online, non-downloadable computer software platform for biomolecule simulation in connection with drug and chemical and material design; providing an online, non-downloadable computer software platform utilizing artificial intelligence and machine learning for biomolecule simulation and synthetic chemistry; providing an online, non-downloadable computer software platform for validating novel disease-related targets; providing temporary use of non-downloadable cloud-based computer software incorporating artificial intelligence and quantum computing functions to automate drug and chemical and material discovery and development; providing temporary use of non-downloadable cloud-based computer software incorporating artificial intelligence and quantum computing functions to automate synthetic chemical discovery and development; providing an online, non-downloadable computer software platform for computational automation of synthetic chemicals; machine learning services, namely, development and training of machine learning algorithms, models, software, applications and solutions for applications in pharmacology, biopharmaceuticals, energy, and optoelectronics; development and design of quantum and hybrid quantum-classical computing software, applications and solutions for manipulating molecules; medical, pharmaceutical and scientific research services; pharmaceutical research and development in the fields of oncology, immunology, cardiology, pulmonology, CNS, psychiatry, dermatology, and endocrinology; pharmaceutical research and development in connection with infectious diseases, diabetes, metabolic diseases, internal diseases, and respiratory diseases; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services, namely, consultation services in the field of development, and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical and material products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical and material products; pharmaceutical, biopharmaceutical, and chemical and material research and development for others |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2019 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 6, 2020 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 20, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Qulab Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90024 |
| Party Name | Qulab Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90024 |
| Event Date | Event Description |
| Monday, December 14, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 14, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, September 14, 2020 | WITHDRAWAL OF ATTORNEY GRANTED |
| Monday, September 14, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Thursday, September 10, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, September 10, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, September 10, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, May 12, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 17, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 17, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 26, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 11, 2020 | ASSIGNED TO LIE |
| Friday, February 7, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, February 6, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 5, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 5, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 3, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, September 3, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 3, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 28, 2019 | ASSIGNED TO EXAMINER |
| Thursday, June 20, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, June 10, 2019 | NEW APPLICATION ENTERED IN TRAM |